Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Glyset
Miglitol is an oral anti-diabetic drug used to manage type 2 diabetes. It belongs to the class of alpha-glucosidase inhibitors, which work by slowing down the digestion and absorption of carbohydrates in the small intestine. This leads to a smaller rise in blood glucose levels after meals, helping to improve glycemic control.
For managing type 2 diabetes by delaying the absorption of carbohydrates.
Outcome:
Increased digoxin levels
Mechanism:
Miglitol may interfere with digoxin absorption.
Outcome:
Additive hypoglycemic effect
Mechanism:
Both drugs lower blood glucose.
Outcome:
Slightly reduced miglitol absorption
Mechanism:
Changes in gastric pH can affect absorption.
Most likely new formulation: sustained-release version (Year 2026, 30% confidence)
Based on current usage patterns and ongoing clinical trials, there is a low probability ( <5%) of any major regulatory changes in the next 2 years.
Alpha-Glucosidase Inhibitor, Antidiabetic Agent
Iminosugar